| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-3-030-25650-0_8 |
| P698 | PubMed publication ID | 31493226 |
| P50 | author | Andrea Ticinesi | Q50569043 |
| P2093 | author name string | Tiziana Meschi | |
| Beatrice Prati | |||
| Antonio Nouvenne | |||
| Claudio Tana | |||
| P2860 | cites work | Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities | Q24647611 |
| Microbial diversity in the human intestine and novel insights from metagenomics | Q33416331 | ||
| The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. | Q33464704 | ||
| Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. | Q33716977 | ||
| Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice | Q64094060 | ||
| Prebiotic supplementation in frail older people affects specific gut microbiota taxa but not global diversity | Q64098968 | ||
| Indoxyl Sulfate Induces Apoptosis Through Oxidative Stress and Mitogen-Activated Protein Kinase Signaling Pathway Inhibition in Human Astrocytes | Q64243038 | ||
| Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism | Q64786944 | ||
| Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers | Q88504264 | ||
| Abnormal gut microbiota composition contributes to cognitive dysfunction in SAMP8 mice | Q89052650 | ||
| Long-Term Genistein Consumption Modifies Gut Microbiota, Improving Glucose Metabolism, Metabolic Endotoxemia, and Cognitive Function in Mice Fed a High-Fat Diet | Q89445907 | ||
| Effects of prebiotics on affect and cognition in human intervention studies | Q90391707 | ||
| Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis | Q90417312 | ||
| Vitamin K Deficiency Induced by Warfarin Is Associated With Cognitive and Behavioral Perturbations, and Alterations in Brain Sphingolipids in Rats | Q90649818 | ||
| Microbiota issue in CKD: how promising are gut-targeted approaches? | Q90703732 | ||
| Low Serum Tryptophan Levels as an Indicator of Global Cognitive Performance in Nondemented Women over 50 Years of Age | Q90746816 | ||
| Probiotic Supplementation in Patients with Alzheimer's Dementia - An Explorative Intervention Study | Q90911545 | ||
| Cultivable butyrate-producing bacteria of elderly Japanese diagnosed with Alzheimer's disease | Q91094879 | ||
| Crosstalk between Gut Microbiota and Central Nervous System: A Focus on Alzheimer's Disease | Q91293746 | ||
| Childhood Obesity and Firmicutes/Bacteroidetes Ratio in the Gut Microbiota: A Systematic Review | Q91295455 | ||
| Effect of combined bifidobacteria supplementation and resistance training on cognitive function, body composition and bowel habits of healthy elderly subjects | Q91352059 | ||
| Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease | Q91451393 | ||
| The Role of Biomarkers in Psychiatry | Q91477391 | ||
| Continuous intracerebroventricular injection of Porphyromonas gingivalis lipopolysaccharide induces systemic organ dysfunction in a mouse model of Alzheimer's disease | Q91751081 | ||
| Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy | Q92001382 | ||
| Indole-3 acetic acid increased risk of impaired cognitive function in patients receiving hemodialysis | Q92074062 | ||
| Quantification of Fecal Short Chain Fatty Acids by Liquid Chromatography Tandem Mass Spectrometry-Investigation of Pre-Analytic Stability | Q92702462 | ||
| APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology | Q92927768 | ||
| The gut microbiota at the intersection of diet and human health | Q93160386 | ||
| Vitamin K status and inflammation are associated with cognition in older Irish adults | Q93207639 | ||
| The intestinal microbiome and its relevance for functionality in older persons | Q93390445 | ||
| Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: A randomized clinical trial | Q61988088 | ||
| Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression | Q63684332 | ||
| The human microbiome in health and disease: hype or hope | Q63952350 | ||
| The gut microbiota composition affects dietary polyphenols-mediated cognitive resilience in mice by modulating the bioavailability of phenolic acids | Q64065394 | ||
| The Relationships Between Vitamin K and Cognition: A Review of Current Evidence | Q64075341 | ||
| Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. | Q34075502 | ||
| Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer's disease β-amyloid oligomerization. | Q34463280 | ||
| Assessing the fecal microbiota: an optimized ion torrent 16S rRNA gene-based analysis protocol | Q34837950 | ||
| Seasonal variation in human gut microbiome composition | Q35117982 | ||
| Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates | Q35662102 | ||
| Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome. | Q35713301 | ||
| Short-chain fatty acids in control of body weight and insulin sensitivity | Q35741824 | ||
| Gut microbiota and aging. | Q35898070 | ||
| Linkage of gut microbiome with cognition in hepatic encephalopathy | Q35939338 | ||
| Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota. | Q35977413 | ||
| Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity | Q36002388 | ||
| Antibiotics as deep modulators of gut microbiota: between good and evil. | Q36105508 | ||
| Looking for a Signal in the Noise: Revisiting Obesity and the Microbiome | Q36111061 | ||
| Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study. | Q36189171 | ||
| Human gut microbiota: the links with dementia development | Q36198753 | ||
| Interaction of gut microbiota with bile acid metabolism and its influence on disease states | Q36204422 | ||
| Dysbiosis and the immune system | Q36297601 | ||
| Pomegranate juice augments memory and FMRI activity in middle-aged and older adults with mild memory complaints. | Q37077931 | ||
| Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer's disease | Q37116609 | ||
| Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota | Q37631109 | ||
| Bacteria as vitamin suppliers to their host: a gut microbiota perspective | Q38039782 | ||
| Preliminary Evidence for an Association Between the Composition of the Gut Microbiome and Cognitive Function in Neurologically Healthy Older Adults | Q38667894 | ||
| Leaky gut - concept or clinical entity? | Q38694531 | ||
| The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis? | Q38877862 | ||
| Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease. | Q38917596 | ||
| Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis | Q38939879 | ||
| Elderly patients have an altered gut-brain axis regardless of the presence of cirrhosis | Q39127475 | ||
| Emerging biomarkers and screening for cognitive frailty | Q39161884 | ||
| Gram-negative bacterial molecules associate with Alzheimer disease pathology | Q39246230 | ||
| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly | Q39254233 | ||
| Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. | Q39393210 | ||
| Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease | Q40178787 | ||
| Neuroprotective Effects of Clostridium butyricum against Vascular Dementia in Mice via Metabolic Butyrate. | Q40927656 | ||
| Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus | Q40978202 | ||
| Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication | Q41033465 | ||
| Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients | Q41328388 | ||
| Microbiome-Derived Lipopolysaccharide Enriched in the Perinuclear Region of Alzheimer's Disease Brain | Q41471296 | ||
| Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1ΔE9 murine model of Alzheimer's disease | Q41620470 | ||
| Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels. | Q42098016 | ||
| Age Drives Distortion of Brain Metabolic, Vascular and Cognitive Functions, and the Gut Microbiome | Q42367849 | ||
| Gut microbiome alterations in Alzheimer's disease | Q42670350 | ||
| Therapeutic potential of Bifidobacterium breve strain A1 for preventing cognitive impairment in Alzheimer's disease | Q42677255 | ||
| Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists | Q43929520 | ||
| Alzheimer's disease and gut microbiota modifications: The long way between preclinical studies and clinical evidence | Q46242741 | ||
| Quantitative microbiome profiling links gut community variation to microbial load. | Q46260477 | ||
| The Gut Metagenome Changes in Parallel to Waist Circumference, Brain Iron Deposition, and Cognitive Function | Q46354626 | ||
| Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State | Q46451309 | ||
| Gut Microbiota Interacts With Brain Microstructure and Function | Q46658369 | ||
| Enterotypes in the landscape of gut microbial community composition. | Q47236614 | ||
| The role of microbial amyloid in neurodegeneration. | Q47265139 | ||
| Aging Gut Microbiota at the Cross-Road between Nutrition, Physical Frailty, and Sarcopenia: Is There a Gut-Muscle Axis? | Q47323507 | ||
| Gut Microbiota and Bone Health | Q47590988 | ||
| Deciphering Diversity Indices for a Better Understanding of Microbial Communities | Q47793438 | ||
| Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset. | Q48439902 | ||
| TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice. | Q48603223 | ||
| Geographical Distribution and Diversity of Gut Microbial NADH:Ubiquinone Oxidoreductase Sequence Associated with Alzheimer's Disease. | Q49613473 | ||
| The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: Comparison between normoweight, overweight-obesity and metabolic syndrome. | Q50212369 | ||
| A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease. | Q50963694 | ||
| Fecal Microbiome Among Nursing Home Residents with Advanced Dementia and Clostridium difficile. | Q51758546 | ||
| Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer's disease during lifespan. | Q51759801 | ||
| Alteration of the fecal microbiota in Chinese patients with Parkinson's disease. | Q52675729 | ||
| The Human Gut Microbiome: From Association to Modulation. | Q52808089 | ||
| Vascular Cognitive Impairment and the Gut Microbiota. | Q53402966 | ||
| Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice. | Q53684068 | ||
| Microbiome-metabolome signatures in mice genetically prone to develop dementia, fed a normal or fatty diet. | Q55192874 | ||
| Vitamin K Antagonists and Cognitive Decline in Older Adults: A 24-Month Follow-Up. | Q55515154 | ||
| Towards microbiome-informed dietary recommendations for promoting metabolic and mental health: Opinion papers of the MyNewGut project | Q56367668 | ||
| Gut microbiota disturbance during antibiotic therapy: a multi-omic approach | Q57155390 | ||
| Gut microbiota associations with common diseases and prescription medications in a population-based cohort | Q57176780 | ||
| Gut Microbiota is Altered in Patients with Alzheimer’s Disease | Q57891363 | ||
| Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers | Q58560352 | ||
| Oral Anticoagulants and Risk of Dementia: A Systematic Review and Meta-analysis of Observational Studies and Randomized Controlled Trials | Q58571135 | ||
| Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review | Q58694401 | ||
| Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial | Q58777287 | ||
| Alterations to the microbiota-colon-brain axis in high-fat diet-induced obese mice compared to diet-resistant mice | Q59328036 | ||
| Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer's Disease | Q59807387 | ||
| An Investigation Into Physical Frailty as a Link Between the Gut Microbiome and Cognitive Health | Q60046797 | ||
| Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases | Q60907545 | ||
| Brain-Gut-Microbiota Axis in Alzheimer's Disease | Q60923090 | ||
| The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer's disease | Q60935789 | ||
| Probiotics and Prebiotics as a Therapeutic Strategy to Improve Memory in a Model of Middle-Aged Rats | Q60949616 | ||
| Analysis of the relationship between the gut microbiome and dementia: a cross-sectional study conducted in Japan | Q61442991 | ||
| Gut Microbiota Dysbiosis Is Not Independently Associated With Neurocognitive Impairment in People Living With HIV | Q61807984 | ||
| Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature | Q61814448 | ||
| Polyphenol Health Effects on Cardiovascular and Neurodegenerative Disorders: A Review and Meta-Analysis | Q61815123 | ||
| The kynurenine pathway and cognitive performance in community-dwelling older adults. The Hordaland Health Study | Q61931276 | ||
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 129-154 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Advances in Experimental Medicine and Biology | Q4686385 |
| P1476 | title | Gut Microbiota and Microbiota-Related Metabolites as Possible Biomarkers of Cognitive Aging | |
| P478 | volume | 1178 |
| Q104459269 | Altered diversity and composition of gut microbiota in Wilson's disease |
| Q98209208 | GUT DYSBIOSIS AND AGE-RELATED NEUROLOGICAL DISEASES; AN INNOVATIVE APPROACH FOR THERAPEUTIC INTERVENTIONS |
Search more.